David Pires
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 21
-
- Force Microscopy Techniques and Applications 5
- Molecular Medicine top 10%
-
- Liquid Crystal Research Advancements 6
- Virology top 10%
- HIV Research and Treatment 7
-
- Mycobacterium research and diagnosis 13
-
- Advancements in Photolithography Techniques 4
-
- Antimicrobial Peptides and Activities 4
-
- Nanofabrication and Lithography Techniques 4
David Pires
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 117
- Infectious Diseases 302
- Atomic and Molecular Physics, and Optics 380
- Molecular Medicine 58
- Electronic, Optical and Magnetic Materials 209
- Virology 46
Countries citing papers authored by David Pires
This map shows the geographic impact of David Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pires more than expected).
Fields of papers citing papers by David Pires
This network shows the impact of papers produced by David Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pires. The network helps show where David Pires may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Pires, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 26 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 41 | |
| 13 | 2016 | 67 | |
| 14 | 2016 | 68 | |
| 15 | 2015 | 8 | |
| 16 | 2015 | 25 | |
| 17 | 2015 | 58 | |
| 18 | 2010 | 139 | |
| 19 | 2010 | 267 | |
| 20 | 2010 | 3 |
About David Pires
David Pires is a scholar working on Virology, Infectious Diseases, Molecular Medicine, Microbiology and Periodontics, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (13 papers), HIV Research and Treatment (7 papers), Liquid Crystal Research Advancements (6 papers), Force Microscopy Techniques and Applications (5 papers), Advancements in Photolithography Techniques (4 papers), Antimicrobial Peptides and Activities (4 papers) and Nanofabrication and Lithography Techniques (4 papers). The work is most often cited by research in Infectious Diseases (302 citations), Atomic and Molecular Physics, and Optics (380 citations), Molecular Medicine (58 citations), Electronic, Optical and Magnetic Materials (209 citations) and Virology (46 citations). David Pires has collaborated with scholars based in Portugal, Switzerland and France. Frequent co-authors include Elsa Anes, Armin W. Knoll, Y. Galerne, Urs Duerig, Jane Frommer, Jean‐Baptiste Fleury, James L. Hedrick, Bernd Gotsmann, José Miguel Azevedo‐Pereira and M. Despont. Their work appears in journals such as Frontiers in Immunology, Pharmaceuticals, Antimicrobial Agents and Chemotherapy, Frontiers in Cellular and Infection Microbiology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.